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Cigarette smokeThe adhesion of monocytic cells to the ‘‘dysfunctional’’ endothelium constitutes a critical step in the
initiation of atherosclerosis. Cigarette smoke (CS) has been shown to contribute to this process, the
complex mechanism of which still needs to be unraveled. We developed an in vitro adhesion assay to
investigate the CS-induced adhesion of monocytic MM6 cells to human umbilical vein endothelial cells
(HUVECs) following exposure to an aqueous CS extract (smoke-bubbled phosphate buffered saline:
sbPBS), reasoning that in vivo monocytes and endothelial cells are exposed primarily to soluble constit-
uents from inhaled CS absorbed through the lung alveolar wall. MM6 cell adhesion was increased exclu-
sively by the conditioned medium from sbPBS-exposed MM6 cells, not by direct sbPBS exposure of the
HUVECs within a range of sbPBS doses. Using a transcriptomics approach followed by conﬁrmation
experiments, we identiﬁed different exposure effects on both cell types and a key mechanism by which
sbPBS promoted the adhesion of MM6 cells to HUVECs. While sbPBS provoked a strong oxidative stress
response in both cell types, the expression of E-selectin, VCAM-1 and ICAM-1, responsible for the adhe-
sion of MM6 cells to HUVECs, was induced in the latter through a proinﬂammatory paracrine effect. We
conﬁrmed that this effect was driven mainly by TNFa produced by MM6 cells exposed to sbPBS. In con-
clusion, we have elucidated an indirect mechanism by which sbPBS increases the adhesion of monocytic
cells to endothelial cells in this in vitro assay that was designed for tobacco product risk assessment while
mimicking the in vivo exposure conditions as closely as possible.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).1. Introduction
Atherosclerosis is the main underlying risk factor for cardiovas-
cular disease, a leading cause of deaths worldwide (Hansson, 2005;
Services, 2010). Although the complex mechanisms leading toatherosclerosis are not yet fully understood, it has been recognized
that the increased adhesion of monocytic cells to the ‘‘dysfunc-
tional’’ or ‘‘activated’’ vascular endothelium is an early, pro-inﬂam-
matory event during the initiation of plaque formation in the
vessel wall (Huang et al., 2011; Kawakami et al., 2006; Libby
et al., 2002; Ross, 1999). The term ‘‘endothelial dysfunction’’ gener-
ally implies a state characterized by diminished production or
availability of nitric oxide leading to impaired vasodilation, and a
shift towards a proinﬂammatory, prothrombotic, pro-oxidative,
and proadhesive phenotype of the endothelium, while the term
‘‘endothelial activation’’ often refers more speciﬁcally to the proin-
ﬂammatory and proadhesive changes occurring in endothelial cells
(Alom-Ruiz et al., 2008; Flammer et al., 2012; Szmitko et al., 2003;
Winkelmann et al., 2009). The active recruitment of monocytes
from the bloodstream by cell–cell adhesion to the luminal surface
of ‘‘activated’’ endothelial cells at sites known to be prone to the
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carotid arteries) is a prerequisite for the subsequent transmigra-
tion of bound monocytes across the endothelium into the intima
region of the vessel wall, where the inﬁltrated monocytes differen-
tiate into foam cells and give rise to fatty streaks and eventually
atherosclerotic plaques (Libby, 2002).
Cigarette smoking is a well-known risk factor for the develop-
ment and progression of atherosclerosis (Burns, 2003; Howard
et al., 1998; Lakier, 1992; Pipe et al., 2010; Tsiara et al., 2003;
Winkelmann et al., 2009). It has been repeatedly demonstrated
that cigarette smoke (CS) inﬂuences the monocyte-endothelial
adhesion process. The adhesion molecules vascular cell adhesion
molecule 1 (VCAM-1), intercellular adhesion molecule 1 (ICAM-
1) and E-selectin, which play major roles in the leukocyte adhe-
sion process and whose expression on the surface of endothelial
cells can be induced by oxLDL, the acute-phase protein high sen-
sitivity C-reactive protein, or by cytokines such as IL-1beta or
TNF alpha, have been shown to be up-regulated by CS
(Szmitko et al., 2003). Indeed, various in vitro assays have dem-
onstrated the inﬂuence of CS or its constituents on the regula-
tion of these adhesion molecules, sometimes with contradictory
results that may in part depend on differences in cell type, CS
fraction (e.g., CS condensate or aqueous extract), and/or exposure
conditions (ﬂow or steady state) (Chen et al., 2004, 2009; Kalra
et al., 1994; Lehr, 1993; Scott and Palmer, 2002; Shen et al.,
1996). In vivo, CS has been shown to induce leukocyte aggrega-
tion and adhesion to endothelium prevented by vitamin C (Lehr
et al., 1994). A signiﬁcant increase in ICAM-1 mRNA was
observed in the coronary arteries of rats exposed to CS daily
for 1 week (Csiszar et al., 2008). Interestingly, sera from smokers
in which increased monocyte-endothelium adhesion was con-
ﬁrmed induced the up-regulation of ICAM-1 in HUVECs (Adams
et al., 1997). This result suggests that the serum of smokers
exhibits properties that favor the process of adhesion. Numerous
population-based studies have shown that the systemic compart-
ment of smokers, compared with that of never-smokers or ex-
smokers, displays a low-grade inﬂammatory response with
increased levels of circulating proinﬂammatory cytokines such
as IL-6 (Bermudez et al., 2002a,b; Woodward et al., 1999). These
cytokines, the systemically distributed soluble constituents and
their metabolites derived from the inhaled CS (absorbed through
the lung alveolar epithelium and the adjacent microvascular
endothelium), or a combination of the two, may have an effect
on the regulation of adhesion molecules in endothelial cells
observed in vivo. This raises important questions regarding
whether soluble CS constituents have a direct and/or indirect
effect on the regulation of VCAM-1, ICAM-1 and E-selectin in
endothelial cells, and the extent to which these molecules are
involved in the process of monocytic cell adhesion to the endo-
thelium. To investigate these questions, we tested the effect of
medium conditioned with an aqueous CS extract in the form
of smoke-bubbled phosphate buffered saline (sbPBS) in an
in vitro adhesion assay. For this purpose, the human monocytic
cell line, Mono Mac 6 (MM6), and human umbilical vein endo-
thelial cells (HUVECs) were used as relevant cellular models to
study the process of adhesion. The adhesion of MM6 cells to
HUVECs using TNFa as an inducer of adhesion has previously
been described by Erl et al. (Erl et al., 1995). MM6 adhesion
was shown to reﬂect mature human monocytes because similar
adhesion parameters were measured, in parallel, in isolated
blood monocytes (Coufﬁnhal et al., 1993; Erl et al., 1995). In
the present study, the in vitro conditioned-medium and adhesion
experiments combined with transcriptomics gene proﬁling and
conﬁrmation experiments enabled to show that sbPBS promotes
the adhesion of monocytic cells to endothelial cells through an
indirect effect, in which TNFa plays a prominent role.2. Material and methods
2.1. Materials
Recombinant TNFa was purchased from R&D Systems (Minne-
apolis, MN, USA). The rat anti-human blocking antibody against
TNFawas purchased from AbD Serotec (cat. No. MCA1560, Kidling-
ton, UK). Murine mAbs were used to block the adhesion molecules,
E-Selectin (R&D cat. No. BBA16), ICAM-1 (Abd Serotec, cat. No.
MCA1615EL), and VCAM-1 (R&D cat. No. BBA5). All blocking
antibodies were IgG1 isotype. The IgG1 isotype controls were pur-
chased from AbD Serotec and R&D Systems (cat No. 5172–6004
and cat. No. MAB002). Collagen A was purchased from Biochrom
(Berlin, Germany).
2.2. Cell culture
Human umbilical vein endothelial cells (HUVECs) were
purchased from PromoCell (Heidelberg, Germany) and cultured
in endothelial growth medium containing supplement mix on
collagen A-coated cell culture dishes. Experiments were performed
at subculture 2–8 using 1-day post-conﬂuent cells. The human
monocytic Mono Mac 6 (MM6) cell line was obtained from Prof.
Ziegler-Heitbrock (University of Leicester, UK). The cells were
maintained in RPMI 1640 containing 10% (vol/vol) fetal calf serum
(FCS), 2 mM L-glutamine, non-essential amino acids (PAA Labora-
tories, Pasching, Austria), 1 mM sodium pyruvic acid, and 9 mg of
bovine insulin (Sigma–Aldrich, Deisenhofen, Germany).
2.3. Preparation of aqueous CS extract, i.e., smoke-bubbled phosphate
buffered saline (sbPBS)
Mainstream smoke from the Reference Cigarette 3R4F (Univer-
sity of Kentucky) was generated on a 20-port Borgwaldt smoking
machine according to ISO standard 3308 and bubbled through
PBS (10 cigarettes/32 mL PBS, 2.5 puffs/mL) at room temperature
as previously described (Muller, 1995; Muller and Gebel, 1994).
This stock solution was diluted in cell culture medium (0.5% FCS)
to obtain the ﬁnal sbPBS concentrations varying from 0.015 to
0.18 puffs/mL. Only freshly prepared sbPBS was used in the
experiments.
2.4. Preparation of conditioned-media
MM6 cells (2  106) were cultured in 6-well culture plates in
standard medium (RPMI 1640 supplemented with 0.5% with FCS
2 h prior treatment with sbPBS). Cells were exposed to several
doses of sbPBS or PBS (solvent control) diluted in starved standard
medium (RPMI1640 with 0.5% FCS) at 37 C for 2 h. Subsequently,
the supernatants and lysates of MM6 cells were collected and
stored at 80 C for the adhesion assay and RNA extraction
(Fig. S1). In parallel, PBS (solvent control) and sbPBS solutions were
diluted in starved standard medium (RPMI1640 with 0.5% FCS),
incubated without any MM6 cell at 37 C for 2 h, and then stored
at 80 C for the adhesion assay.
2.5. Treatment of HUVECs or HCAECs with conditioned-medium
HUVECs or HCAECs were grown as monolayers in collagen-
coated 48-well culture plates until conﬂuent in endothelial growth
culture medium from PromoCell (Heidelberg, Germany). Cells were
then starved overnight in the same medium containing 0.5% FCS
and incubated for 4 h with the supernatant from MM6 cells
exposed to sbPBS or PBS (indirect treatment). In parallel, HUVECs
and HCAECs were exposed directly to PBS or sbPBS diluted in
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ment; description in ‘‘Preparation of conditioned-media’’ section)
(Fig. S1). Cell lysates were collected and stored at 80 C for RNA
extraction and protein quantiﬁcation using the In-Cell Western™
assay.
2.6. RNA preparation
RNA from HUVECs, HCAECs and MM6 cell lysates was extracted
using the RNeasy Midi Kit (Qiagen, Hilden, Germany) and stored at
80 C. Puriﬁed RNA was quantiﬁed using the Nanodrop ND-1000
(PEQLAB, Erlangen, Germany), and RNA integrity was determined
using the Agilent 2100 Bioanalyzer (Agilent, Waldbronn, Ger-
many). All RNA samples showed a RIN > 9.5.
2.7. Analysis of gene expression by reverse transcriptase real-time
quantitative PCR (RT-qPCR)
RT-qPCR was performed using the High Capacity cDNA Reverse
Transcription Kit and the following Taqman Assay-on-demand kits
from Applied Biosystems (Darmstadt, Germany): ICAM-1 (NCBI
reference sequence, NM_000201.1), VCAM-1 (NCBI reference
sequence, NM_001078.2), and a-E-Selectin (NCBI reference
sequence, NM_000450.1). For ﬁrst-strand cDNA synthesis, 2 lg of
total RNA were used in a ﬁnal reaction volume of 100 lL. qPCRs
were performed with 20 ng ﬁrst-strand cDNA/reaction in triplicate
(10 lL ﬁnal volume each) in 384-well plates. Of the panel of house-
keeping genes tested, GAPDH showed the most constant expres-
sion levels and was therefore used as an endogenous control for
normalization. RT-qPCR data were analyzed using the comparative
CT method for relative quantiﬁcation.
2.8. Microarray analysis
Transcriptome analysis was performed according to the
Affymetrix Gene Chip Expression Analysis Technical Manual
(Santa Clara, CA. USA). Brieﬂy, after synthesis of double-stranded
cDNA from 100 ng total RNA, biotinylated cRNA was generated
and fragmented. The degree of fragmentation and the length distri-
bution of this fragmented biotinylated cRNA was checked by
capillary electrophoresis using the Agilent 2100 Bioanalyzer. Ten
lg of biotinylated fragmented cRNA were hybridized to GeneChip
HG-U133 Plus 2.0 for 16 h at 60 rpm in a 45 C GeneChip Hybrid-
ization Oven 640 (Affymetrix). The arrays were washed and
stained on the GeneChip Fluidics Station 450 (Affymetrix) fol-
lowed by antibody signal ampliﬁcation, washing, and staining
using streptavidin R-phycoerythrin. The arrays were scanned using
the Agilent GeneArray Scanner 3000 7G. Scanned image ﬁles were
visually inspected for artifacts before analysis. Each image was
scaled to the same all probe set intensities for comparison between
chips. The GeneChip Command Console Software (AGCC) was
used to control the ﬂuidics station and the scanner was used to
measure probe array intensity signals, applying the default param-
eters provided in the Affymetrix data analysis software package.
2.9. In vitro adhesion assay
Conﬂuent HUVEC or HCAEC monolayers were grown on colla-
gen-coated 48-well culture plates, starved overnight in medium
containing 0.5% FCS, treated with supernatants from MM6 cells
exposed to sbPBS or PBS (indirect treatment) for 4 h, and then
washed once with PBS. Untreated, ﬂuorescently-stained (cell
tracker orange, CMTMR) MM6 cells (106) were added to each well.
After 45 min, the nuclei of all cells were stained with Hoechst dye
for 15 min. After washout, the cells were ﬁxed with 10% glutaralde-
hyde. The adhering MM6 cells were counted using the CellomicsArrayScan VTI automated ﬂuorescence microscope (Thermo Fisher
Scientiﬁc, Pittsburgh, PA, USA).
2.10. Cytokine assay
TNFa levels were determined using an ELISA kit for cytokine
detection (Ref. DY210, R&D Systems) based on the quantitative
sandwich enzyme immunoassay technique.
2.11. Blocking antibodies
Blocking antibodies against the adhesion molecules, ICAM-1,
VCAM-1 and E-selectin, were used in the adhesion assay. The con-
ﬂuent HUVEC monolayer was pre-incubated with 1% BSA for 1 h
before adding 10 lg/mL of speciﬁc blocking antibodies or mouse
IgG1 isotype control. After incubation for 30 min, the monocytes
were added and the adhesion assay was performed as previously
described. The blocking TNFa antibody was added to the
supernatant of the MM6 cells at concentrations ranging from 0.1
to 1 lg/mL. The HUVEC monolayers were treated for 4 h with this
supernatant supplemented with anti-TNFa antibody or with IgG1
isotype control, and the adhesion assay was performed as
described above.
2.12. Transcriptomics data analysis
Raw data (Cel ﬁles are available in the ArrayExpress database
with the entry ID: E-MTAB-1173) were pre-processed and normal-
ized with GC-Robust Multiarray Average (GCRMA) (Wu et al.,
2004). An analysis was conducted to control the quality of all
arrays by generating different diagnostic plots (e.g. NUSE, RLE,
pseudo-images, etc.). All arrays were of good quality and kept for
further data analysis. Normalized data were also batch corrected
for the cell lot effect using ComBat (Johnson et al., 2007). The iden-
tiﬁcation of differentially regulated genes for the effects of interest
in all datasets was performed with Bioconductor’s limma package
(Smyth, 2004). P-values were adjusted using Benjamini and Hoch-
berg method due to multiple hypothesis testing (Benjamini and
Hochberg, 1995). For the HUVEC and HCAEC datasets, a linear
model was deﬁned to estimate different effects: Gene expression 
b0 + bm Medium + bt  Treatment + bi Medium  Treatment +
e (eq1)
The experimental design included two factors: ‘‘Medium’’ with
two levels, (a) standard medium alone (M: medium) and (b) super-
natant from MM6 cells grown in this standard medium (Su: super-
natant); and ‘‘Treatment’’ also with two levels, (a) PBS
corresponding to sham condition (S) and (b) sbPBS corresponding
to treated condition (T). The bm, bt, and bi coefﬁcients of the linear
model (eq1) were estimated for each probe set, respectively: (i) the
MM6 supernatant ‘‘Medium’’ effect (SuS) independently of the
sbPBS ‘‘Treatment’’ effect comparing the conditions where HUVECs
were exposed to supernatant from PBS-treated MM6 cells or to
standard medium containing PBS (control medium); (ii) the sbPBS
‘‘Treatment’’ effect (SmM) independently of the MM6 supernatant
‘‘Medium’’ effect comparing the conditions where HUVECs were
exposed to sbPBS or to PBS, both in standard medium; and (iii)
the interaction effect between the two factors (Interaction) corre-
sponding to the differential effect of the sbPBS ‘‘Treatment’’ effect
observed in HUVECs in presence of MM6 supernatant or of stan-
dard medium conditions, also similarly formulated as the differen-
tial effect of the MM6 supernatant ‘‘Medium’’ effect (SuS) observed
in HUVECs exposed to PBS or to sbPBS. Differentially expressed
genes regulated by TNFa were identiﬁed by comparing the condi-
tions in which HUVECs were treated with TNFa or with control
medium (see above). For the MM6 dataset, the identiﬁcation of
genes differentially regulated by the aqueous CS extract was per-
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All R packages (affy, simpleaffy, gcrma, affyPLM, limma) used to
conduct the data analysis were included in the Bioconductor 2.6
version. The R version used was 2.11.2.13. Gene set enrichment analysis (GSEA)
To identify activated processes/pathways to support the biolog-
ical interpretation of the effects, GSEA was performed with the C2
gene set collection from the Molecular Signature Database
(MSigDBv3.0; http://www.broadinstitute.org/gsea/msigdb/collec-
tions.jsp), and all differential gene expression regulation proﬁles
corresponding to the effects of interest for HUVECs (SuS, SmM,
Interaction, TNF) and MM6 cells described above. The FDR associ-
ated to each gene set was computed as described in Subramanian
et al. (Subramanian et al., 2005). In order to compare HUVEC and
HCAEC gene expression proﬁles, GSEA was also used to assess
the enrichment of HCAEC differentially regulated genes in HUVEC
gene expression regulation proﬁles.2.14. Statistical analysis
Treatment effect in the adhesion assay (± different blocking
antibodies), TNFa levels measured in MM6 supernatant, and on
the gene expression level measured by RT-qPCR were tested by
one-way ANOVA followed by Dunnett post hoc test. The linear
model (y  Dose + Experiment; ‘‘Dose’’ as a factor) deﬁned for the
ANOVA also included the variable ‘‘experiment’’ as a blocking fac-
tor. The R software version 2.15.1 was used for the statistical anal-
ysis. Post-hoc tests were carried out using the ‘‘multcomp’’ R
package (version 1.2–18).VC
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followed by Dunnett post hoc test. *P < 0.05; **P < 0.01.3. Results
3.1. Expression of the adhesion molecules, VCAM-1, ICAM-1 and E-
selectin, increased only after indirect treatment of endothelial cells
with aqueous CS extract (sbPBS)
To determine whether soluble CS constituents have a direct or
indirect effect on the regulation of VCAM-1, ICAM-1 and E-selectin
expression in endothelial cells, HUVECs were treated with sbPBS or
PBS (direct treatment) or with supernatants from monocytic MM6
cells exposed to sbPBS or PBS (indirect treatment). Quantiﬁcation
of mRNA by RT-qPCR revealed a signiﬁcant dose-dependent
increase in the expression of the three adhesion molecules in
HUVECs treated for 4 h with supernatant from MM6 cells exposed
to sbPBS (indirect treatment) (Fig 1A). No change in ICAM-1
expression was observed when HUVECs were exposed to sbPBS
(direct treatment), while VCAM-1 and E-selectin were down-regu-
lated (Fig. 1B). These results were conﬁrmed at the protein level
(Fig. S2). Although in three independent experiments statistical
signiﬁcance was only reached for E-selectin protein, a clear dose-
dependent increase in ICAM-1 and VCAM-1 proteins was observed
in HUVECs after indirect treatment, but not after direct treatment,
with sbPBS (Fig. S2).3.2. The adhesion of MM6 cells to endothelial cells increased after
indirect treatment of endothelial cells with sbPBS
To investigate the impact of the up-regulation of adhesion mol-
ecules by indirect treatment with sbPBS on the monocyte-endothe-
lium adhesion process, an optimized in vitro adhesion assay was
developed with MM6 cells and an endothelial cell monolayer of
HUVECs. Treatment of HUVECs with supernatant from MM6
cells exposed to sbPBS (indirect treatment) resulted in aE-selectin
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900 C. Poussin et al. / Toxicology in Vitro 28 (2014) 896–908dose-dependent increased adhesion of MM6 cells to the endothe-
lial cells (Fig. 2). Indeed, the number of red dots, which correspond
to monocytic cells adhering to HUVECs (blue dots), was signiﬁ-
cantly enhanced by increasing sbPBS concentrations in the MM6
supernatant (more than 2 times compared with solvent control),
as observed by microscopy and quantiﬁed on the ArrayScan
(Fig. 2A and B). The maximum adhesion rate was observed with
a 0.09 puffs/mL sbPBS dose. For direct treatment, no adhesion of
MM6 cells to HUVECs was observed for sbPBS doses up to
0.09 puffs/mL, and a mild dose-dependent increase of adhesion
was observed for higher doses (0.12 and 0.18 puffs/mL) (Data not
shown).
3.3. Supernatant from MM6 cells exposed to sbPBS caused a signiﬁcant
inﬂammatory response in HUVECs, while direct and indirect sbPBS
treatment induced an oxidative stress response
To investigate which factors in the MM6 supernatant promoted
the adhesion of MM6 cells to HUVECs, microarray data were gen-
erated for both cell types (Fig. S1). The sbPBS dose of 0.09 puffs/
mL was used since the maximum of adhesion rate was
observed with this dose for indirect treatment. Analysis of theA 
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by Dunnett post hoc test. ***P < 0.0001. (For interpretation of the references to color in ttranscriptomics data allowed us to identify the genes in HUVECs
that were signiﬁcantly regulated by three main effects, as
described in Fig. S1. The ﬁrst effect was due to the MM6 superna-
tant only (SuS), as demonstrated by comparison of HUVECs
exposed to either ‘‘supernatant from PBS-treated MM6 cells’’ or
‘‘PBS in standard medium’’. The second effect was caused by direct
sbPBS treatment (SmM), as demonstrated by comparison of
HUVECs exposed to ‘‘sbPBS in standard medium’’ or ‘‘PBS in stan-
dard medium’’. The third effect was due to the interaction between
the MM6 supernatant and sbPBS treatment. This interaction (I)
corresponds to the differential effect of sbPBS (relative to PBS) on
HUVECs incubated in MM6 supernatant or standard medium
(SmSu-SmM). Similarly, this interaction can also be interpreted
as a differential effect of MM6 supernatant (relative to standard
medium) on HUVECs exposed to sbPBS or to PBS (SuT-SuS). In
addition, transcriptomics data from MM6 cells were analyzed to
identify genes whose expression was regulated by sbPBS compared
with PBS. The supernatants used to treat HUVECs were those
obtained from the same MM6 cells from which RNA was extracted
for transcriptomics analysis.
To identify the biological processes regulated by the different
effects of interest (SuS, SmM, I, TNF) in HUVECs, gene setTNFα  0.129
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m MM6 cells for 4 h before adhesion was measured. The solvent control condition
g/mL) was used as a positive control for the experiment. One-way ANOVA followed
his ﬁgure legend, the reader is referred to the web version of this article.)
Table 1
Gene sets enriched in the gene expression regulation proﬁles associated with the different estimated effects of interest observed in HUVECs. Following GSEA, gene sets (with
FDR 6 0.05 for at least one effect of interest) were grouped according to the biological processes/pathways they represent. Normalized enrichment scores (NES) with FDR 6 0.05
are highlighted in bold italic. I: interaction.
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als and Methods. The effects could be differentiated by three main
biological processes: stress response, cell division/growth-metabo-
lism, and inﬂammatory response, reﬂected by clustered gene sets
(identiﬁed by PCA, data not shown) displayed in Table 1. The
results showed the differential regulation of genes involved in
the inﬂammatory response according to the medium conditions
(Table 1, Fig. 3A–C). Indeed, the interaction effect (comparison of
the sbPBS effect relative to PBS in MM6 supernatant and standard
medium) revealed a signiﬁcant increase in the expression of genes
belonging to the NFjB signaling pathway and downstream cyto-
kine genes (e.g., IL-1, IL-8, IL-15, MCP-1), chemokine genes (e.g.,
CX3CL1, CXCL1, CXCL3, CXCL2, CXCL5, CCL2), and adhesion mole-
cule genes (e.g., VCAM-1, ICAM-1, SELE, CD69, CD83) implicated
in monocytic cell adhesion. These gene expression changes are
highlighted in the GSEA results and in the modiﬁed view of the
‘‘Role of Macrophages, Fibroblasts and Endothelial cells in Rheuma-
toid Arthritis’’ Ingenuity canonical pathway representative of a
typical inﬂammatory response (IPA: Ingenuity Pathway Analysis
software, Ingenuity Systems, www.ingenuity.com) (Table 1,
Figs. 3A, and S3). The expression of the transcription factor NFjB
itself was observed to be signiﬁcantly enhanced (Fig. 3E). When
HUVECs were exposed to supernatant fromMM6 cells treated with
PBS only (SuS effect), a very mild inﬂammatory response was
observed (Fig. 3B). Conversely, sbPBS diluted in standard medium
(SmM effect) repressed the inﬂammatory response mediated by
the NFjB signaling pathway (Fig. 3C and Table 1). However, signif-
icant enrichment of genes up-regulated by the stress response was
observed (Fig. S4 and Table 1). More speciﬁcally, this stress
response was reﬂected by the signiﬁcant enrichment of gene sets
representative of hypoxia, unfolded protein response, redox, anti-
oxidant activities, and detoxiﬁcation processes (Table 1). More-
over, an important group of gene sets corresponding to MAPK
signaling activation was signiﬁcantly enriched in the up-regulated
genes in the HUVEC expression regulation proﬁles (Table 1).
Among the leading edge genes signiﬁcantly enriched, Nrf2 target
genes were identiﬁed. Interestingly, the effect of sbPBS on the
stress response was found to be similar in standard medium and
MM6 supernatant medium, as observed by the expression pattern
of up-regulated genes (e.g., HMOX1, SQSTM1, GCLM, TXNRD1)
under oxidative stress conditions (Fig. S4). Our conditioned-med-
ium experiment with HCAECs followed by transcriptomics analysis
revealed similar differential expression proﬁles to those observed
in HUVECs (Fig. S5A and B).
3.4. HUVECs treated with TNFa or with supernatant from MM6 cells
exposed to sbPBS displayed similar inﬂammatory gene expression
regulation proﬁles
The GSEA results highlighted similar inﬂammatory responses in
HUVECs exposed to supernatant from sbPBS-treated MM6 cells
(interaction effect) or TNFa which was used as a positive control
for inﬂammation. Indeed, identical gene sets were signiﬁcantly
enriched in the respective expression proﬁles, and most of the
leading edge genes contributing to these enriched proﬁles were
common to both conditions (Table 1). The visualization of differen-
tially expressed genes for the interaction and TNF effects onto a
pathway representative of an inﬂammatory response (modiﬁed
view of the ‘‘Role of Macrophages, Fibroblasts and Endothelial cells
in Rheumatoid Arthritis’’ canonical pathway from Ingenuity) (IPA)
revealed very similar patterns (Fig. 3A and D). To investigate our
hypothesis that TNFa may be present in the supernatant of MM6
cells exposed to sbPBS and thus contribute to the observed gene
expression regulation proﬁles in HUVECs treated with this super-
natant, GSEA was carried out with speciﬁcally selected gene sets
representative of the TNFa effect gathered from diverse internaland public datasets (MSigDB). The results indicated that these gene
sets were signiﬁcantly enriched in the gene expression regulation
proﬁle corresponding to the interaction effect in HUVECs (Table 2).
Overall, these ﬁndings suggest that TNFa was present as a soluble
factor in the MM6 supernatant and was a key driver mediating the
inﬂammatory response in HUVECs.
3.5. sbPBS promotes the up-regulation of genes involved in the
oxidative stress and inﬂammatory responses in MM6 cells
GSEA (data not shown) and Ingenuity Pathway Analysis (Inge-
nuity Systems, www.ingenuity.com) of MM6 gene expression
regulation proﬁles derived from the comparison of sbPBS and
PBS highlighted, on one hand, the signiﬁcant over-representation
of oxidative stress genes (‘‘NRF2-mediated Oxidative Stress
Response pathway’’ was the most signiﬁcant canonical pathway
in Ingenuity, with a FDR of 9.52  104), and on the other hand,
inﬂammation processes (FDR associated with Inﬂammatory
Response functions ranged from 1.33  103 to 2.05  102 in
Ingenuity), as shown in Fig. 4. At this time, a causal relationship
between the activation of oxidative stress and inﬂammatory path-
ways cannot be inferred. Many of the observed up-regulated genes
for the oxidative stress response are known to be direct targets of
the transcription factor, Nrf2 (Fig. 4A). Regarding the ‘‘inﬂamma-
tory response’’ gene sets/pathways, many genes corresponded to
cytokines (e.g., IL-1b, IL-8) and chemokines (e.g., CXCL1, CXCL2,
CXCL3, CCL3, CCL4, CCL20) (Fig. 4B). The expression of TNFa was
also signiﬁcantly increased by sbPBS (Fig. 4B).
3.6. TNFa in the supernatant of MM6 cells exposed to sbPBS plays a
major role in the adhesion of MM6 cells to HUVECs
To conﬁrm the results obtained from the gene expression data,
the level of TNFa protein was measured by ELISA in the superna-
tant of MM6 cells exposed to PBS or sbPBS. The treatment of
MM6 cells with sbPBS resulted in a signiﬁcant and dose-dependent
release of TNFa into the supernatant (Fig. 5A). Interestingly, a max-
imum TNFa release was observed with a dose of sbPBS of
0.12 puffs/mL, and then decreased with higher doses (0.15 and
0.18 puffs/mL). To further investigate the contribution/role of TNFa
in the adhesion of MM6 cells to HUVECs, a speciﬁc TNFa blocking
antibody was used. The antibody or an IgG isotype control was
added to the sbPBS-exposed MM6 supernatant before treatment
of the HUVEC monolayer with the supernatant. In the presence
of different TNFa antibody concentrations, the number of MM6
cells adhering to the endothelial cells was found to be signiﬁcantly
reduced compared with the IgG isotype control (Fig. 5B). In addi-
tion, the amplitude of the reduction was proportional to the con-
centration of blocking TNFa antibody present in the supernatant.
3.7. The adhesion of MM6 cells to HUVECs occurs mainly through
E-selectin and VCAM-1
Gene expression data (RT-qPCR and microarray) indicated that
E-selectin, VCAM-1 and ICAM-1 were among the most highly reg-
ulated adhesion molecules in HUVECs. Therefore, we investigated
to what extent these proteins were implicated in the adhesion of
MM6 cells to HUVECs under indirect treatment conditions by using
speciﬁc blocking antibodies for ICAM-1, VCAM-1 and E-Selectin.
Pre-incubation of HUVECs with the blocking antibodies led to a sig-
niﬁcant decrease in the adhesion of MM6 cells to HUVECs. The
strongest impact was observed with the anti-E-selectin antibody
(Fig. 6). This result suggested that E-selectin plays a major role in
the adhesion process, which was conﬁrmed using different combi-
nations of these blocking antibodies (Fig. S6).
SmM effect 
Interaction effectA B 
C D 
SuS effect 
TNF effect 
E 
1 2 3 4 1 2 3 4 1 2 3 4 1 2 3 4 
Fig. 3. Differential regulation of the inﬂammatory response in HUVECs upon exposure to various medium conditions. (A–C) Genes exhibiting signiﬁcant differential regulation for
the effects of interest (I, interaction: FDR6 0.001, SuS: FDR 6 0.05, SmM: FDR6 0.001) or (D) for the effect of TNFa used as positive control (TNF: FDR6 0.001) weremapped onto
an inﬂammatory response pathway corresponding to a modiﬁed view of the ‘‘Role of Macrophages, Fibroblasts and Endothelial cells in Rheumatoid Arthritis’’ canonical pathway
from Ingenuity. The nodes in the pathway marked in red and green correspond to signiﬁcantly up- and down-regulated genes, respectively. (E) The bar plots represent the
expression in log2 of NFjB-related genes for the different experimental conditions in HUVECs. The interaction value reported for each plot corresponds to the following difference:
[sbPBS-PBS] MM6 supernatant -[sbPBS-PBS] Standard medium. 1 – PBS in standard medium; 2 – sbPBS in standard medium; 3 – Supernatant of PBS-treated MM6 cells; 4 – Supernatant of
sbPBS-treated MM6 cells (see Fig. S1). (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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Table 2
Supernatant from MM6 cells exposed to sbPBS induced a similar inﬂammatory response to that observed with TNFa in HUVECs. Various gene sets representative of a TNFa gene
expression response fromMSigDB and our internal gene set database were found to be signiﬁcantly enriched in the gene expression regulation proﬁle representing the interaction
effect in HUVECs. UP and DN indicate that the expressed genes present in the gene sets were up- or down-regulated by TNFa respectively.
Gene set name NES FDR Information
HUVEC_[TNF]_UP 3.95 0 Internal data
HCAEC_[TNF]_UP 3.91 0 Internal data
SANA_TNF_SIGNALING_UP 2.96 0 PMID 15749026
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP 2.91 0 PMID 19010928
TIAN_TNF_SIGNALING_VIA_NFKB 2.37 0 PMID 15722553
BIOCARTA_TNFR2_PATHWAY (NFkB pathway activation) 2.08 0.0001 Biocarta
BIOCARTA_TNFR1_PATHWAY (Apoptosis) 0.84 0.79 Biocarta
SANA_TNF_SIGNALING_DN 2.13 0 PMID15749026
ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN 2.16 0 PMID 19010928
HCAEC_[TNF]_DN 3.48 0 Internal data
HUVEC_[TNF]_DN 3.57 0 Internal data
(relative to control: PBS)
Gene 
Symbol Gene Name
log2[Fold 
Change] FDR
CCL20 chemokine (C-C motif) ligand 20 3.1 0.000684
CCL3 chemokine (C-C motif) ligand 3 1.1 0.013763
CXCL1 chemokine (C-X-C motif) ligand 1 3.4 0.000472
CXCL2 chemokine (C-X-C motif) ligand 2 4.2 0.000179
CXCL3 chemokine (C-X-C motif) ligand 3 3.6 0.001966
IL1B interleukin 1, beta 1.4 0.012728
IL8 interleukin 8 3.0 0.00035
TNF tumor necrosis factor 1.9 0.00387
B 
A 
Fig. 4. Activation of the expression of genes implicated in the oxidative stress response and inﬂammatory activities by sbPBS in MM6 cells. (A) Simpliﬁed view of the ‘‘Nrf2-
mediated Oxidative Stress Response’’ canonical pathway from Ingenuity. The nodes in the pathway colored in red and green correspond to signiﬁcantly up- and down-
regulated genes, respectively (FDR 6 0.05). (B) Signiﬁcantly regulated genes encoding cytokines and chemokines in MM6 cells. (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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In this work, we have investigated the molecular mechanism by
which aqueous CS extract (sbPBS) promotes the adhesion of mono-
cytic MM6 cells to endothelial cells (HUVECs) using an in vitro
adhesion assay together with a transcriptomics approach and sub-sequent experimental conﬁrmation. We discovered a key underly-
ing molecular mechanism of monocyte-endothelium adhesion
driven by an indirect effect of sbPBS.
The dose-dependent increase in the expression of the adhesion
molecules, ICAM-1, VCAM-1 and E-selectin, and in the adherence
of MM6 cells to HUVECs following the exposure of HUVECs to
C. Poussin et al. / Toxicology in Vitro 28 (2014) 896–908 905supernatant from sbPBS-treatedMM6 cells (indirect condition), sug-
gested that certain factors present in the supernatant induced the
adhesion of MM6 cells to HUVECs. These factors possibly originate
from MM6 cells exposed to sbPBS and from sbPBS itself containing
soluble CS constituents present in the supernatant. This indirect con-
dition mimics to some extend the in vivo situation where soluble CS
constituents that pass the lung barrier to the systemic compartment
may have an effect on circulating monocytic cells, on one hand and
also on endothelial cells covering vessel intima on the other hand
(Yamaguchi et al., 2007; Zhang et al., 2010). However, in in vivo stud-
ies it is not possible, when analyzing overall molecular changes (e.g.
gene expression) in endothelial cells, to deconvolute the effects
induced by soluble CS constituents and those induced by other sol-
uble factors present in plasma which composition (e.g. cytokines,
oxLDL) can be altered upon cigarette smoke exposure. The factorial
design of our experiment leveraging an in vitro adhesion assay com-
bined with a transcriptomics approach enabled to discriminate
those effects in HUVECs and to understand the ones that drive the
process of monocyte-endothelial cell adhesion.
Comparison of the effect of sbPBS (interaction effect) on
HUVECs revealed a strong proinﬂammatory response in HUVECs
only in indirect condition. Our results indicate that this inﬂamma-A 
B 
sbPBS (puff
MM6 Su
++
+ + 
0.1 IgG 
Supernatant
from MM6 cells
exposed to PBS
++
+
Fig. 5. TNFa released by MM6 cells exposed to sbPBS plays a major role in the adhesion
mL) present in the supernatant of sbPBS-treated MM6 cells (3 independent experiments i
exposure to different sbPBS concentrations (0–0.18 puffs/mL). Mean ± SEM. LPS (1 lg/mL
to PBS-treated MM6 supernatant used as negative control for the experiment. (B) Bars rep
relative to control conditions in which HUVECs were incubated with supernatant from PB
TNFa antibody were added to the MM6 supernatant (0.09 puffs/mL MM6 supernatant
supplemented with the anti-TNFa antibody or IgG1 isotype control for 4 h. After washing
The number of MM6 cells adhered to HUVECs was counted on the ArrayScan. Mean ± SEtory response may be driven by the activation of the NFjB signal-
ing pathway that may lead to increased expression of
proinﬂammatory mediators such as cytokines and chemokines
and, importantly, adhesion molecules ICAM-1, VCAM-1 and
E-selectin. Conversely, standard medium supplemented with
sbPBS (relative to PBS; direct condition) decreased the inﬂamma-
tory response in HUVECs, leading to the observed decrease in
ICAM-1, VCAM-1 and E-selectin. These results indicate that the
inﬂammatory response observed in HUVECs differs upon the con-
text of medium that contains on one side, proinﬂammatory medi-
ators secreted by MM6 cells and soluble CS constituents for
indirect condition, and on the other side, soluble CS constituents
only for direct condition. Some papers have shown that the cellular
inﬂammatory response can decrease if cells are pre-exposed/pre-
conditioned to oxidants (Loukili et al., 2010; Zahler et al., 2000),
while the inﬂammatory response is ampliﬁed if cells are post-
exposed to oxidants (Loukili et al., 2010). Oxidants modify the
intracellular redox state balance that can regulate the activity of
NFjB through the modulation of its translocation into nucleus
(Schreck et al., 1991), its binding on speciﬁc DNA sites (Gebel
and Muller, 2001; Hayashi et al., 1993), negative feedback-loop
of its own regulation (Lombardi et al., 1995), and also, throughs/mL) treated-
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Fig. 6. Key role of E-selectin and VCAM-1 in the adhesion of MM6 cells to HUVECs exposed to the supernatant of sbPBS-treated MM6 cells. Bars represent the mean number of
MM6 cells adherent to HUVECs expressed as fold change relative to control conditions in which HUVECs were incubated with supernatant from PBS-treated MM6 cells (3
independent experiments). HUVECs were treated with supernatant from sbPBS-treated MM6 cells (0.09 puffs/mL) for 4 h, followed by a blocking step with PBS containing 1%
BSA for 1 h. HUVECs were then incubated with anti-VCAM-1, anti-E-selectin or anti-ICAM-1 antibodies, or IgG1 isotype control (10 lg/mL) for 30 min. After washing 3 times
with PBS, untreated MM6 cells were added to the HUVEC culture for 45 min. The number of MM6 cells adhered to HUVECs was counted on the ArrayScan. Mean ± SEM. One-
way ANOVA followed by Dunnett post hoc test. *P < 0.05.
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phosphorylation of IKK upstream of IkB-NFkB complex) (Loukili
et al., 2010). This might explain the context-dependent induction
and repression of adhesion molecules ICAM-1, VCAM-1 and
E-selectin, target genes of the NFjB transcription factor, and could
be investigated further. The use of speciﬁc blocking antibodies for
ICAM-1, VCAM-1 and E-selectin in the adhesion assay implied their
role in the adhesion of MM6 cells to HUVECs. Maximum inhibition
of adhesion was observed with the anti-E-selectin antibody,
suggesting a key role for E-selectin in the adhesion process.
While sbPBS induced opposite effects (activation or repression)
with regard to the inﬂammatory response in HUVECs depending on
the medium used (MM6-supernatant vs. standard medium), sbPBS
activated a similar oxidative stress response in both media. Single
oxidative stressors, such as peroxynitrite and aldehydes, have been
shown to be formed by CS in aqueous solutions and may contribute
to the cellular oxidative stress response in HUVECs (Muller and
Gebel, 1998; Muller et al., 1997). Overall, our results suggest that
this oxidative stress response reﬂects downstream transcriptional
effects (possibly driven by Nrf2) of soluble CS constituents, and
does not directly promote the inﬂammatory response that is
increased only in indirect conditions. However, the oxidative stress
response may modulate the already induced inﬂammatory
response by balancing the intracellular redox state through the
synthesis of antioxidant proteins (e.g. see Fig. S4, e.g. TXNRD1)
(Gebel and Muller, 2001).
Our computational analysis enabled to show that HUVECs
exposed to supernatant from sbPBS-treated MM6 cells (interaction
effect) displayed a similar gene expression response proﬁle to that
observed with TNFa. TNF-a has been shown to increase the
expression of adhesion molecules in HUVECs (Ikuta et al., 1991).
We hypothesized that TNFa was present in the supernatant of
sbPBS-treated MM6 cells and contributed to the observed adhesion
of MM6 cells to HUVECs. Our results indicate that sbPBS increased
TNFa at the mRNA and protein levels in MM6 cells. Moreover,
when TNFa blocking antibodies were added to the supernatant
of sbPBS-treated MM6 cells, the adhesion of MM6 cells to HUVECs
was blocked. These ﬁndings conﬁrm our hypothesis that TNFa
plays a major role in the response of HUVECs to supernatant from
sbPBS-treated MM6 cells.Venous HUVECs are often used as surrogates for the endothelial
cells in the arterial vessels at risk (e.g., coronary, carotid). Our con-
ditioned-medium experiment with human coronary arterial endo-
thelial cells (HCAECs) followed by transcriptomics analysis
revealed similar differential expression proﬁles to those observed
in HUVECs.
Altogether, the transcriptomics data and the subsequent valida-
tion experiments enabled us to postulate the following monocyte-
endothelial cell adhesion mechanism induced by aqueous CS
extract. As shown in Fig. 7, the monocytic MM6 cells exposed to
sbPBS were activated and released soluble inﬂammatory mediators
into the culture medium (supernatant). When exposed to this
medium, HUVECs reacted directly by an oxidative stress response
to the soluble CS constituents on one hand, and were activated
by MM6-produced soluble mediators, inducing an inﬂammatory
response on the other hand. One of these key soluble mediators
is TNFa, which plays a major role in this response leading to a sig-
niﬁcant increase in the expression of genes involved in cell adhe-
sion. The augmentation of those adhesion molecules, particularly
E-selectin and VCAM-1, on the surface of HUVECs is then account-
able for the observed increase in adhesion of MM6 cells to HUVECs.
Likewise, the increased adhesion of monocytic THP-1 cells to TNF-
activated HUVECs was accompanied by elevated surface expres-
sion of ICAM-1, VCAM-1, and E-selectin (Chen and Khismatullin,
2012).
In agreement with our results, Zhang et al. showed that the
effect of water-soluble CS extract on the release of soluble ICAM-
1 by HUVECs was mediated through macrophages (ANA-1 macro-
phage cell line), possibly by inducing TNFa release (Zhang et al.,
2002). Other studies reported that CS extract or CS bubbled into
growth medium increased TNFa at the transcript and protein level
in alveolar macrophages, THP-1 and peripheral blood monocytic
cells (PBMC) (Churg et al., 2003; Wright et al., 2012). In addition,
similarly to our study, an increased oxidative stress response has
been observed in monocytic cells exposed to CS extract (Wright
et al., 2012).
If we extrapolate the interpretation to the in vivo context, on
one side, the endothelium exposed to plasmatic inﬂammatory fac-
tors produced by monocytic or other cells exposed to CS constitu-
ents might induce adhesive properties due to increased adhesion
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Fig. 7. Schematic representation of the effects of aqueous CS extract on MM6 cells and HUVECs in direct and indirect treatment conditions.
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side, the endotheliummight undergo an oxidative stress due to CS-
derived oxidants and toxic compounds present in the plasma. As
conﬁrmed by numerous population-based studies, the systemic
compartment of smokers displays low-grade inﬂammatory as well
as oxidative stress properties (Yanbaeva et al., 2007). These charac-
teristics possibly contribute concomitantly to endothelial dysfunc-
tion, thus giving rise to the development of atherosclerosis
(Yanbaeva et al., 2007). Recent independent studies reported that
TNFa levels are signiﬁcantly higher in the sera of smokers com-
pared with non-smokers, and that TNFa levels are signiﬁcantly
reduced following smoking cessation (Barbieri et al., 2011;
Petrescu et al., 2010; Reichert et al., 2009). In that context, an
important question concerns the origin of TNFa. The source might
be multiple tissues exposed to CS directly, such as lung epithelial
cells or alveolar macrophages, or indirectly, such as circulating
monocytes activated by soluble CS constituents that passed the
lung barrier to the systemic compartment. Moreover, it has been
recognized that in addition to TNFa, other systemic inﬂammatory
mediators such as IL-1 beta, C-reactive protein (CRP), and lipopro-
teins (e.g. LDL or ApoCIII-rich VLDL) can activate endothelial cell
adhesive properties in vitro (Szmitko et al., 2003);(Kawakami
et al., 2006; Westhorpe et al., 2012). Although our current assay
design elucidated only the TNFa-driven component (which
explained a prominent amount of the total proadhesive endothelial
cell activation by the MM6 mediated sbPBS exposure), the
described approach would also allow to investigate separately
the molecular pathway contribution of other proinﬂammatory
mediators on endothelial cell activation. With regard to the appli-
cation of this in vitro assay in product testing, such additional char-
acterization might increase the comprehensiveness in representing
the in vivo endothelial activating potential of CS under simpliﬁed
and deﬁned in vitro conditions.
As mentioned in the results section, at higher doses of sbPBS
(0.12 and 0.18 puffs/mL), the adhesion of MM6 cells to HUVECs
mildly increases for direct treatment (Data not shown) while it
decreases for indirect treatment. This observation suggests that
different underlying mechanisms lead to the adhesion of MM6
cells to HUVECs, and might explain the discrepancy of results
reported on the effect of CS extract on adhesion in the literature.
The mechanism of adhesion for direct treatment would require
to be further investigated.
In conclusion, in this study, the use of an in vitro adhesion assay
that mimics in vivo conditions combined with a systems biology
approach and conﬁrmation experiments showed a mechanism by
which the adhesion of monocytic MM6 cells to endothelial cells
(HUVECs) was triggered through an indirect effect of the aqueousCS extract within a range of sbPBS doses. Future in vivo and
in vitro investigations are needed to conﬁrm these results in the
pathological context of atherosclerosis.
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